PR Newswire (press release), NY -In the news release, Lexicon Pharmaceuticals (Nasdaq: LXRX) Announces Two Agreements, issued yesterday by Lexicon Pharmaceuticals, Inc. over PR Newswire, ...<br><img src="/images/chart_7777cc3.gif" class="ticker-icon" width="14" height="12"><a href="http://finance.google.com/finance?q=LXRX&client=news" class="rich">LXRX</a><a href="http://sev.prnewswire.com/biotechnology/20070618/CLM10018062007-1.html" id=r-4_0>BioCryst Presents Phase I Peramivir Data at the Options for the ...</a><br>PR Newswire (press release), NY - 17 minutes ago<br>BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat ...<br><img src="/images/chart_7777cc3.gif" class="ticker-icon" width="14" height="12"><a href="http://finance.google.com/finance?q=BCRX&client=news" class="rich">BCRX</a><a href="http://sev.prnewswire.com/entertainment/20070618/AQMFNS0118062007-1.html" id=r-5_0>Major New Book Refutes 'Clash Of Civilizations,' Shows Early ...</a><br>PR Newswire (press release), NY - 17 minutes ago<br>... they reverberate even today -- in computation, digital appliances, surgery and pharmaceuticals, film and books, modern universities and global commerce. ...

::Read the Full Article